Article
Genetically proxied impaired GIPR signaling and risk of 6 cancers
9 May 2023
Abstract excerpt
Preclinical and genetic studies suggest that impaired glucose-dependent insulinotropic polypeptide receptor (GIPR) signaling worsens glycemic control. The relationship between GIPR signaling and the risk of cancers influenced by impaired glucose homeostasis is unclear. We examined the association of a variant in GIPR , rs1800437 (E354Q), shown to impair long-term GIPR signaling and lower circulating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
